Cargando…

Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial

The aim of this trial was to investigate whether stroke patients who receive Cerebrolysin show improved motor function in the upper extremities at day 90 compared with patients who receive a placebo. METHODS—: This study was a prospective, randomized, double-blind, placebo-controlled, multicenter, p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muresanu, Dafin F., Heiss, Wolf-Dieter, Hoemberg, Volker, Bajenaru, Ovidiu, Popescu, Cristian Dinu, Vester, Johannes C., Rahlfs, Volker W., Doppler, Edith, Meier, Dieter, Moessler, Herbert, Guekht, Alla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689177/ https://www.ncbi.nlm.nih.gov/pubmed/26564102 http://dx.doi.org/10.1161/STROKEAHA.115.009416

Ejemplares similares

Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials
por: Guekht, Alla, et al.
Publicado: (2017)

Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials
por: Bornstein, Natan M., et al.
Publicado: (2017)

Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke
por: Bajenaru, O, et al.
Publicado: (2010)

Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial
por: Gharagozli, K, et al.
Publicado: (2017)

Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery
por: Jianu, DC, et al.
Publicado: (2010)

Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study
por: Strilciuc, Stefan, et al.
Publicado: (2023)

Role and Impact of Cerebrolysin for Ischemic Stroke Care
por: Mureșanu, Dafin F., et al.
Publicado: (2022)

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
por: Rockenstein, Edward, et al.
Publicado: (2014)

Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer’s Disease
por: Alvarez, X Anton, et al.
Publicado: (2020)

The Effect of Cerebrolysin on Anxiety, Depression, and Cognition in Moderate and Severe Traumatic Brain Injury Patients: A CAPTAIN II Retrospective Trial Analysis
por: Mureșanu, Ioana Anamaria, et al.
Publicado: (2022)

Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases
por: Alvarez, X. Anton, et al.
Publicado: (2016)

Cerebrolysin administration reduces oxidative stress-induced apoptosis in limphocytes from healthy individuals
por: Formichi, Patrizia, et al.
Publicado: (2012)

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson’s Disease
por: Rockenstein, Edward, et al.
Publicado: (2016)

Effects of cerebrolysin on nerve growth factor system in the aging rat brain
por: Stepanichev, Mikhail, et al.
Publicado: (2017)

Cerebrolysin and repetitive transcranial magnetic stimulation (rTMS) in patients with traumatic brain injury: a three-arm randomized trial
por: Verisezan Rosu, Olivia, et al.
Publicado: (2023)

Cerebrolysin Attenuates Heat Shock Protein (HSP 72 KD) Expression in the Rat Spinal Cord Following Morphine Dependence and Withdrawal: Possible New Therapy for Pain Management
por: Sharma, Hari S, et al.
Publicado: (2011)

Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin
por: Onose, G, et al.
Publicado: (2009)

C-REGS 2 - Design and methodology of a high-quality comparative effectiveness observational trial
por: Vester, Johannes, et al.
Publicado: (2021)

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies
por: Rockenstein, Edward, et al.
Publicado: (2015)

ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment
por: Guekht, Alla, et al.
Publicado: (2017)

Celebrating the legacy of Prof. Ovidiu Alexandru Bajenaru
por: Muresanu, Dafin, et al.
Publicado: (2022)

Effects and tolerability of betahistine in patients with vestibular vertigo: results from the Romanian contingent of the OSVaLD study
por: Băjenaru, Ovidiu, et al.
Publicado: (2014)

Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50–60 nm) Nanoparticles
por: Sharma, Hari Shanker, et al.
Publicado: (2023)

The Effect of Cerebrolysin on the Predictive Value of Baseline Prognostic Risk Score in Moderate and Severe Traumatic Brain Injury
por: Birle, Codruta, et al.
Publicado: (2020)

Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study
por: Stan, A, et al.
Publicado: (2017)

In memoriam: Professor Ovidiu Alexandru Bajenaru (1957-2020)
por: Muresanu, Dafin
Publicado: (2020)

2021: New horizons in neurorehabilitation
por: Muresanu, Dafin
Publicado: (2021)

Efficacy of Cerebrolysin in the reduction of spasticity during stroke rehabilitation
por: Martinez, RM
Publicado: (2017)

Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis
por: Jarosz, Konrad, et al.
Publicado: (2023)

Academia steps up to strengthen health policymaking in Romania: a roadmap for tackling difficulties encountered by Ministry of Health specialty commissions
por: Muresanu, Dafin, et al.
Publicado: (2021)

Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage
por: Woo, Peter Y. M., et al.
Publicado: (2020)

Brain recovery – towards an unified theory
por: Mureşanu, Dafin F
Publicado: (2010)

Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats
por: Georgy, Gehan S., et al.
Publicado: (2013)

Role of Cerebrolysin(®) in Rehabilitation in Ischemic Stroke: A Case Report
por: Chanubol, Ratanapat, et al.
Publicado: (2021)

Cerebrolysin Use in Patients with Liver Damage—A Translational Study
por: Morega, Shandiz, et al.
Publicado: (2022)

Editorial: The Clinical Neuroscience of Music: Evidence Based Approaches and Neurologic Music Therapy
por: Thaut, Michael H., et al.
Publicado: (2021)

The Silver Lining in a Time of Crisis: The Foundation of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN) Conference Proceedings Go Virtual
por: Muresanu, Dafin, et al.
Publicado: (2020)

New evidence for the pharmacological intervention promoting neurorecovery after stroke: results from the joint EAN-EFNR guidelines
por: Muresanu, Dafin, et al.
Publicado: (2021)

Continuing the Journey: The Second Edition of the Neurotrauma Treatment Simulation Center (NTSC)
por: Chira, Diana, et al.
Publicado: (2023)

Effect size measures and their benchmark values for quantifying benefit or risk of medicinal products
por: Rahlfs, Volker, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_av6fvq5pcvrh7gp59t46ajb0qu